Skip to content
The Policy VaultThe Policy Vault

Ferriprox oral solutionMedica

patients who meet the standard Chelating Agents – Iron Chelators (Oral) Prior Authorization Policy criteria

Preferred products

  • generic deferasirox tablets
  • generic deferasirox tablets for suspension
  • generic deferasirox granules
  • generic deferiprone tablets

Initial criteria

  • Patient meets the standard Chelating Agents – Iron Chelators (Oral) Prior Authorization Policy criteria; AND
  • Patient meets ONE of the following (i, ii, or iii):
  • i. Patient has tried ONE of generic deferasirox tablets, generic deferasirox tablets for suspension, generic deferasirox granules, or generic deferiprone tablets; OR
  • ii. The dose prescribed cannot be attained with deferiprone tablets; OR
  • iii. Patient cannot swallow or has difficulty swallowing deferiprone tablets.

Approval duration

1 year